Approaching Inflammation Paradoxes—Proinflammatory Cytokine Blockages Induce Inflammatory Regulators
Ming Liu,Jason Saredy,Ruijing Zhang,Ying Shao,Yu Sun,William Y. Yang,Jirong Wang,Lu Liu,Charles Drummer,Candice Johnson,Fatma Saaoud,Yifan Lu,Keman Xu,Li,Xin Wang,Xiaohua Jiang,Hong Wang,Xiaofeng Yang
DOI: https://doi.org/10.3389/fimmu.2020.554301
IF: 7.3
2020-01-01
Frontiers in Immunology
Abstract:The mechanisms that underlie various inflammation paradoxes, metabolically healthy obesity, and increased inflammations after inflammatory cytokine blockades and deficiencies remain poorly determined. We performed an extensive -omics database mining, determined the expressions of 1367 innate immune regulators in 18 microarrays after deficiencies of 15 proinflammatory cytokines/regulators and eight microarray datasets of patients receiving Mab therapies, and made a set of significant findings: 1) proinflammatory cytokines/regulators suppress the expressions of innate immune regulators; 2) upregulations of innate immune regulators in the deficiencies of IFN gamma/IFN gamma R1, IL-17A, STAT3 and miR155 are more than that after deficiencies of TNF alpha, IL-1 beta, IL-6, IL-18, STAT1, NF-kB, and miR221; 3) IFN gamma, IFN gamma R and IL-17RA inhibit 10, 59 and 39 proinflammatory cytokine/regulator pathways, respectively; in contrast, TNF alpha, IL-6 and IL-18 each inhibits only four to five pathways; 4) The IFN gamma-promoted and -suppressed innate immune regulators have four shared pathways; the IFN gamma R1-promoted and -suppressed innate immune regulators have 11 shared pathways; and the miR155-promoted and -suppressed innate immune regulators have 13 shared pathways, suggesting negative-feedback mechanisms in their conserved regulatory pathways for innate immune regulators; 5) Deficiencies of proinflammatory cytokine/regulator-suppressed, promoted programs share signaling pathways and increase the likelihood of developing 11 diseases including cardiovascular disease; 6) There are the shared innate immune regulators and pathways between deficiency of TNF alpha in mice and anti-TNF therapy in clinical patients; 7) Mechanistically, up-regulated reactive oxygen species regulators such as myeloperoxidase caused by suppression of proinflammatory cytokines/regulators can drive the upregulation of suppressed innate immune regulators. Our findings have provided novel insights on various inflammation paradoxes and proinflammatory cytokines regulation of innate immune regulators; and may re-shape new therapeutic strategies for cardiovascular disease and other inflammatory diseases.